Literature DB >> 626319

Splenectomy for massive splenomegaly.

J Goldstone.   

Abstract

Removal of a massively enlarged spleen is a challenging surgical problem that is associated with higher death and complication rates than the removal of smaller spleens. Older age, serious and chronic primary diseases, and associated cardiopulmonary abnormalities contribute to the morbidity and mortality. Most patients with massive splenomegaly have been treated with corticosteroid and/or antineoplastic drugs, which impair wound healing, hemostatic function, and host resistance. Precise surgical technic is especially important in these cases because of the susceptibility to postoperative hemorrhage. Ligation of the splenic artery via the lesser peritoneal sac before mobilization of the spleen is associated with lower intraoperative transfusion requirements than when the spleen is mobilized before the splenic artery is ligated.

Entities:  

Mesh:

Year:  1978        PMID: 626319     DOI: 10.1016/0002-9610(78)90071-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  12 in total

1.  Laparoscopic splenectomy for hematologic diseases: a preliminary analysis performed on the Italian Registry of Laparoscopic Surgery of the Spleen (IRLSS).

Authors:  M Casaccia; P Torelli; S Squarcia; M P Sormani; A Savelli; B Troilo; G Santori; U Valente
Journal:  Surg Endosc       Date:  2006-07-03       Impact factor: 4.584

2.  Does open surgery continue to have a role in elective splenectomy?

Authors:  A P Boddy; D Mahon; M Rhodes
Journal:  Surg Endosc       Date:  2006-05-13       Impact factor: 4.584

3.  Does splenectomy in cystic fibrosis related liver disease improve lung function and nutritional status? A case series.

Authors:  B Linnane; M R Oliver; P J Robinson
Journal:  Arch Dis Child       Date:  2006-05-31       Impact factor: 3.791

4.  Partial splenic embolization: experience in 136 patients.

Authors:  O Jonasson; D G Spigos; M F Mozes
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

5.  Splenectomy for massive splenomegaly.

Authors: 
Journal:  Br Med J       Date:  1979-08-04

6.  Outcome of laparoscopic splenectomy with preoperative splenic artery embolization for massive splenomegaly.

Authors:  Artan Reso; Mantaj Singh Brar; Neal Church; Philip Mitchell; Elijah Dixon; Estifanos Debru
Journal:  Surg Endosc       Date:  2010-04-24       Impact factor: 4.584

7.  Laparoscopic splenectomy.

Authors:  E C Poulin; C Thibault; J Mamazza
Journal:  Surg Endosc       Date:  1995-02       Impact factor: 4.584

8.  Partial splenectomy in cystic fibrosis patients with hypersplenism.

Authors:  G H Thalhammer; E Eber; S Uranüs; J Pfeifer; M S Zach
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

9.  Massive splenomegaly is associated with significant morbidity after laparoscopic splenectomy.

Authors:  Ameet G Patel; Jane E Parker; Ben Wallwork; Keith B Kau; Nora Donaldson; Michael R Rhodes; Nicholas O'Rourke; Les Nathanson; George Fielding
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

10.  Telaprevir-based triple therapy following partial splenic arterial embolization for chronic hepatitis C with thrombocytopenia can reduce carcinogenesis and improve hepatic function reserve.

Authors:  Toru Ishikawa; Satoshi Abe; Yuichi Kojima; Ryoko Horigome; Tomoe Sano; Akito Iwanaga; Keiichi Seki; Terasu Honma; Toshiaki Yoshida
Journal:  Exp Ther Med       Date:  2015-08-07       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.